Skip to main content
. 2018 Jul;7(4):470–482. doi: 10.21037/acs.2018.07.02

Figure 5.

Figure 5

Two-year clinical outcomes among the study patients, compared with the equipoise-derived SYNTAX I CABG cohort—exploratory analysis. Kaplan-Meier curves are shown for the SYNTAX II group (blue) and the surgical revascularization arm of the original SYNTAX I trial (red) for the major adverse cardiac or cerebrovascular events (MACCE). Presentation of SYNTAX II 2-year results at EuroPCR 2018, Paris, France.